miércoles, 4 de noviembre de 2020

Rapid generation of divergent synthetic antibodies against SARS-CoV-2 in a cell-free engineering platform

Rapid generation of divergent synthetic antibodies against SARS-CoV-2 in a cell-free engineering platform

No hay comentarios:

Publicar un comentario